Bacteriophage lambda display systems: Developments and applications

Applied Microbiology and Biotechnology

Volumn 98, Issue 7, 2014, Pages 2853-2866

  Nicastro, Jessica ^a   Sheldon, Katlyn ^a   Slavcev, Roderick A ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Bacteriophage ; Gene delivery; gpD translational fusion; Lytic phage display; Phage vaccine

Indexed keywords

DISPLAY DEVICES; GENE TRANSFER; MOLECULAR BIOLOGY; VACCINES;

CAPSID ASSEMBLIES; FUTURE APPLICATIONS; GENE DELIVERY; MOLECULAR GENETICS; PHAGE DISPLAY; PHAGE DISPLAY TECHNOLOGY; STERIC HINDRANCES; TRANSLATIONAL FUSION;

BACTERIOPHAGES;

CAPSID PROTEIN; CHIMERIC PROTEIN; DNA VACCINE; ENHANCED GREEN FLUORESCENT PROTEIN; HEPATITIS B SURFACE ANTIGEN; HYDROLASE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TRANSACTIVATOR PROTEIN; TRANSFER RNA;

BACTERIOPHAGE; BIOLOGICAL CONTROL; BIOTECHNOLOGY; GENETIC ANALYSIS; MOLECULAR ANALYSIS; VACCINE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BACTERIAL STRAIN; BACTERIOPHAGE LAMBDA; BACTERIOPHAGE T4; BACTERIOPHAGE T7; BACTERIUM DETECTION; CARBOXY TERMINAL SEQUENCE; CRYOELECTRON MICROSCOPY; ESCHERICHIA COLI; FILAMENTOUS PHAGE; GENE TARGETING; GENE TRANSFER; GENETIC REGULATION; HUMAN; IMAGE PROCESSING; IMMUNE RESPONSE; INTERNALIZATION; LYTIC PHAGE; NONHUMAN; PEPTIDE LIBRARY; PHAGE DISPLAY; POINT MUTATION; PROMOTER REGION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; STEREOSPECIFICITY; STOP CODON; VACCINATION; VIRUS CAPSID;

ENTEROBACTERIA PHAGE LAMBDA; MIRIDAE;

BACTERIOPHAGE LAMBDA; CELL SURFACE DISPLAY TECHNIQUES; MEMBRANE PROTEINS; RECOMBINANT PROTEINS; VIRAL STRUCTURAL PROTEINS;

EID: 84898872608     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-014-5521-1     Document Type: Review

References (102)

1. Barry M, Dower W, Johnston SA (1996) Toward cell-targetting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med 2:299-305
2. Bastien N, Trudel M, Simard C (1997) Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus. Virology 234:118-22
3. Benzer S, Champe SP (2013) A change from nonsense to sense in the genetic code. Proc Natl Acad Sci U S A 48:1114-1121
4. Bernard H, Remaut E, Hershfield M, Das H, Helinski D, Yanofsky C, Franklin N (1979) Construction of plasmid cloning vehicles that promote gene expression from the bacteriophage lambda pL promoter. Gene 5:59-76
5. Bolle A (1964) Co-Linearity of the gene with the polypeptide chain. Nature 201:13-17
6. Breitling R, Sorokin A, Behnke D (1990) Temperature-inducible gene expression in Bacillus subtillis mediated by the cI857-encoded repressor of bacteriophage lambda. Gene 93:35-40
7. Brenner S, Stetton O, Kaplan S (1965) Genetic code: the "nonsense" triplets for chain termination and their suppression. Nature 206:994-998
8. Brigati J, Williams DD, Sorokulova IB, Nanduri V, Chen I-H, Turnbough CL, Petrenko VA (2004) Diagnostic probes for Bacillus anthracis spores selected from a landscape phage library. Clin Chem 50:1899-906
9. Clark JR, Bartley K, Jepson CD, Craik V, March JB (2011) Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B. FEMS Immunol Med Microbiol 61:197-204
10. Clark JR, March JB (2006) Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends Biotechnol 24:212-8
11. Clark JR, March JB (2004) Bacteriophage-mediated nucleic acid immunisation. FEMS Immunol Med Microbiol 40:21-26
12. d'Herelle F, Smith G. (1926) The bacteriophage and its behavior. 413-424.
13. Dabrowska K, Opolski A, Gorski A (2005) Bacteriophage penetration in vertebrates. J Appl Microbiol 7-13
14. Dai M, Temirov J, Pesavento E, Kiss C, Velappan N, Pavlik P, Werner JH, Bradbury ARM (2008) Using T7 phage display to select GFP-based binders. Protein Eng Des Sel: PEDS 21:413-24
15. Dickerson TJ, Kaufmann GF, Janda KD (2005) Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy. Pept Proteins Antisense 5:773-81
16. Dokland T, Murialdo H (1993) Structural transitions during maturation of bacteriophage lambda capsids. J Mol Biol 233:682-694
17. Duckworth DH (1976) Who discovered bacteriophage? Bacteriol Rev 40:793-802
18. Dulbecco R (1982) Viruses with recombinant surface proteins. 8.
19. Dunn IS (1995) Assembly of functional bacteriophage lambda virions incorporating C-terminal peptide or protein fusions with the major tail protein. J Mol Biol 248:497-506
20. Dunn IS (1996) Mammalian cell binding and transfection mediated by surface-modified bacteriophage lambda. Biochimie 137:37
21. Efimov VP, Nepluev IV, Mesyanzhinov VV (1995) Bacteriophage T4 as a surface display vector. Virus Genes 10:173-7
22. Eguchi A, Akuta T, Okuyama H, Senda T, Yokoi H, Inokuchi H, Fujita S, Hayakawa T, Takeda K, Hasegawa M, Nakanishi M (2001) Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J Biol Chem 276:26204-10
23. Fischetti VA (2005) Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol 13:491-6
24. Funatsu T, Taniyama T, Tajima T, Tadakuma H, Namiki H (2002) Rapid and sensitive detection method of a bacterium by using a GFP reporter phage. Microbiol Immunol 46:365-369
25. Gamage LNA, Ellis J, Hayes S (2009) Immunogenicity of bacteriophage lambda particles displaying porcine Circovirus 2 (PCV2) capsid protein epitopes. Vaccine 27:6595-604
26. Garufi G, Minenkova O, Lo Passo C, Pernice I, Felici F (2005) Display libraries on bacteriophage lambda capsid. Biotechnol Annu Rev 11:153-90
27. Gulig P, Martin J, Messer HG, Deffense BL, Harpley CJ (2008) Phage display methods for detection of bacterial pathogens. In: Zourpb M, Elwary S, Turner A (eds) Principles of bacterial detection: biosensors regognition receptors and microsystems. Springer, Montreal, Canada, pp 755-783
28. Gupta A, Onda M, Pastan I, Adhya S, Chaudhary VK (2003) High-density Functional Display of Proteins on Bacteriophage Lambda. J Mol Biol 334:241-254
29. Guzmán CA, Piatti G, Walker MJ, Guardati MC, Pruzzo C (1994) A novel Escherichia coli expression-export vector containing alkaline phosphatase as an insertional inactivation screening system. Gene 148:171-2
30. Haq IU, Chaudhry WN, Akhtar MN, Andleeb S, Qadri I (2012) Bacteriophages and their implications on future biotechnology: a review. Virol J 9:9
31. Hart SL, Knight AM, Harbottle RP, Mistry A, Hunger HD, Cutler DF, Williamson R, Coutelle C (1994) Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide. J Biol Chem 269:12468-74
32. Hayes S, Gamage LNA, Hayes C (2010) Dual expression system for assembling phage lambda display particle (LDP) vaccine to porcine Circovirus 2 (PCV2). Vaccine 28:6789-99
33. Hayes S, Hayes C (1986) Spontaneous lambda OR mutations suppress inhibition of bacteriophage growth by nonimmune exclusion phenotype of defective lambda prophag. J Virol 58:835-842
34. Hohn T, Katsura I (1977) Structure and assembly of bacteriophage lambda. In: Current Topics in Microbiology and Immunology SE - 3. Springer, Berlin Heidelberg, pp 69-110
35. Ide T, Bik S, Matsuba T, Marayama SH (2003) Identifcation by the phage-display technique of peptides that bind to H7 flagellin of Escherichia coli. Biosci Biotechnol Biochem 67:1335-1341
36. Imber R, Tsugita A, Wurtz M, Hohn T (1980) Outer surface protein of bacteriophage lambda. J Mol Biol 139:277-95
37. Inokuchi H, Yamao F, Sakano H, Ozeki H (1979) Identification of transfer RNA suppressors in Escherichia coli. J Mol Biol 132:649-662
38. Jechlinger W, Szostak MP, Witte A, Lubitz W (1999) Altered temperature induction sensitivity of the lambda pR/cI857 system for controlled gene E expression in Escherichia coli. FEMS Microbiol Lett 173:347-52
39. Jepson CD, March JB (2004) Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle. Vaccine 22:2413-9
40. Jestin J-L (2008) Functional cloning by phage display. Biochimie 90:1273-8
41. Kaiser AD (1966) On the internal structure of bacteriophage lambda. J Gen Physiol 49:171-8
42. Kalniņa Z, Siliņa K, Meistere I, Zayakin P, Rivosh A, Abols A, Leja M, Minenkova O, Schadendorf D, Lině A (2008) Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients. J Immunol Methods 334:37-50
43. Katsura I (1988) Structure and inherent properties of the bacteriophage lambda head shell major capsid protein. Most 397-405.
44. Kaur T, Nafissi N, Wasfi O, Sheldon K, Wettig S, Slavcev R (2012) Immunocompatibility of bacteriophages as nanomedicines. J Nanotechnol 2012:1-13
45. Lander GC, Evilevitch A, Jeembaeva M, Potter CS, Johnson JE (2008) Bacteriophage lambda stabilization by auxiliary protein gpD: timing, location, and mechanism of attachment determined by cryoEM. Structure 16:1399-1406
46. Lankes HA, Zanghi CN, Santos K, Capella C, Duke CMP, Dewhurst S (2007) In vivo gene delivery and expression by bacteriophage lambda vectors. J Appl Microbiol 102:1337-49
47. Larocca D, Baird A (2001) Receptor-mediated gene transfer by phage-display vectors: applications in functional genomics and gene therapy. Drug Discov Today 6:793-801
48. Li P, Yu L, Wu X, Bai W, Li K, Wang H, Hu G, Zhang L, Zhang F, Xu Z (2012) Modification of the adenoviral transfer vector enhances expression of the Hantavirus fusion protein GnS0.7 and induces a strong immune response in C57BL/6 mice. J Virol Methods 179:90-96
49. Lieb M (1966) Studies of heat-inducible lambda bacteriophage. J Mol Biol 16:149-163
50. Lindqvist B (2005) Phage in Display, Second Edi. 686-694
51. Ling Y, Liu W, Clark JR, March JB, Yang J, He C (2011) Veterinary immunology and immunopathology protection of mice against Chlamydophila abortus infection with a bacteriophage-mediated DNA vaccine expressing the major outer membrane protein. Vet Immunol Immunopathol 144:389-395
52. Loessner MJ, Rudolf M, Scherer S (1997) Evaluation of luciferase reporter bacteriophage A511::luxAB for detection of Listeria monocytogenes in contaminated foods. Appl Environ Microbiol 63:2961-2965
53. Lowman HB, Bina M (1990) Temperature-mediated regulation and downstream inducible selection for controlling gene expression from the bacteriophage lambda pL promoter. Gene 96:133-6
54. Lukacik P, Barnard TJ, Keller PW, Chaturvedi KS, Seddiki N, Fairman JW, Noinaj N, Kirby TL, Henderson JP, Steven AC, Hinnebusch BJ, Buchanan SK (2012) Structural engineering of a phage lysin that targets gram-negative pathogens. Proc Natl Acad Sci U S A 109:9857-62
55. Malanchère-Brès E, Payette PJ, Mancini M, Tiollais P, Davis L, Michel M (2001) CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice. J Virol 75:6482-6491
56. March JB, Clark JR, Jepson CD (2004) Genetic immunisation against hepatitis B using whole bacteriophage λ particles. Vaccine 22:16666-1671
57. Maruyama IN, Maruyama HI, Brenner S (1994) Lambda foo: a lambda phage vector for the expression of foreign proteins. Proc Natl Acad Sci U S A 91:8273-7
58. Mattiacio J, Walter S, Brewer M, Domm W, Friedman AE, Dewhurst S (2011) Dense display of HIV-1 envelope spikes on the lambda phage scaffold does not result in the generation of improved antibody responses to HIV-1 Env. Vaccine 29:2637-2647
59. Mikawa YG, Maruyama IN, Brenner S (1996) Surface display of proteins on bacteriophage lambda heads. J Mol Biol 262:21-30
60. Min J-J, Nguyen VH, Gambhir SS (2010) Molecular imaging of biological gene delivery vehicles for targeted cancer therapy: beyond viral vectors. Nucl Med Mol Imaging 44:15-24
61. Minenkova O, Pucci A, Pavoni E, De Tomassi A, Fortugno P, Gargano N, Cianfriglia M, Barca S, De Placido S, Martignetti A, Felici F, Cortese R, Monaci P (2003) Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients. Int J Cancer J Int Cancer 106:534-44
62. Mott JE, Grant RA, Ho YS, Platt T (1985) Maximizing gene expression from plasmid vectors containing the lambda PL promoter: strategies for overproducing transcription termination factor rho. Proc Am Thorac Soc 82:88-92
63. Mullen LM, Nair SP, Ward JM, Rycroft AN, Henderson B (2006) Phage display in the study of infectious diseases. Trends Microbiol 14:141-7
64. Nakanishi M, Eguchi A, Akuta T, Nagoshi E, Fujita S, Okabe J, Senda T, Hasegawa M (2003) Basic peptides as functional components of non-viral gene transfer vehicles. Curr Protein Pept Sci 4:141-150
65. Nicastro J, Sheldon K, El-Zarkout FA, Sokolenko S, Aucoin MG, Slavcev R (2013) Construction and analysis of a genetically tuneable lytic phage display system. Appl Microbiol Biotechnol 97:7791-7804
66. Normanly J, Massont J, Kleinat LG, Abelson J, Millert JH (1986) Construction of two Escherichia coli amber suppressor genes: tRNAPheCUA and tRNACysCUA. Proc Am Thorac Soc 83:6548-6552
67. Oda M, Morita M, Unno H, Tanji Y (2004) Rapid detection of Escherichia coli O157:H7 by using green fluorescent protein-labeled PP01 bacteriophage. Appl Environ Microbiol 70:527-534
68. Olsen EV, Sorokulova IB, Petrenko VA, Chen I-H, Barbaree JM, Vodyanoy VJ (2006) Affinity-selected filamentous bacteriophage as a probe for acoustic wave biodetectors of Salmonella typhimurium. Biosens Bioelectron 21:1434-42
69. Pavoni E, Vaccaro P, Pucci A, Monteriù G, Beghetto E, Barca S, Dupuis ML, De Pasquale CA, Lugini A, Cianfriglia M, Cortesi E, Felici F, Minenkova O (2004) Identification of a panel of tumor-associated antigens from breast carcinoma cell lines, solid tumors and testis cDNA libraries displayed on lambda phage. BMC Cancer 4:78
70. Petrenko VA, Vodyanoy VJ (2003) Phage display for detection of biological threat agents. J Microbiol Methods 53:253-262
71. Petty NK, Evans TJ, Fineran PC, Salmond GPC (2007) Biotechnological exploitation of bacteriophage research. Trends Biotechnol 25:7-15
72. Piersanti S, Cherubini G, Martina Y, Salone B, Avitabile D, Grosso F, Cundari E, Di Zenzo G, Saggio I (2004) Mammalian cell transduction and internalization properties of lambda phages displaying the full-length adenoviral penton base or its central domain. J Mol Med (Berlin, Germany) 82:467-76
73. Remaut E, Stanssens P, Fiers W (1981) Plasmid vectors for high-efficiency expression controlled by the pL promoter of coliphage lambda. Gene 15:81-93
74. Ren ZJ, Lewis GK, Wingfield PT, Locke EG, Steven AC, Black LW (1996) Phage display of intact domains at high copy number: a system based on SOC, the small outer capsid protein of bacteriophage T4. Protein Sci 5:1833-1843
75. Saïda F, Uzan M, Odaert B, Bontems F (2006) Expression of highly toxic genes in E. Coli: special strategies and genetic tools. Curr Protein Pept Sci 7:47-56
76. Santini C, Brennan D, Mennuni C, Hoess RH, Nicosia A, Cortese R, Luzzago A (1998) Efficient display of an HCV cDNA expression library as C-terminal fusion to the capsid protein D of bacteriophage lambda. J Mol Biol 282:125-35
77. Sapinoro R, Volcy K, Rodrigo WWSI, Schlesinger JJ, Dewhurst S (2008) Fc receptor-mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cells. Virology 373:274-286
78. Seow Y, Wood MJ (2009) Biological gene delivery vehicles: beyond viral vectors. Mol Ther: J Am Soc Gene Ther 17:767-77
79. Smith GP (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion. Adv Sci 228:1315-1317
80. Smith H, Huggins M (1982) Successful treatment of experimental Escherchia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 128:307-318
81. Sokolenko S, Nicastro J, Slavcev R, Aucoin MG (2012) Graphical analysis of flow cytometer data for characterizing controlled fluorescent protein display on λ phage. Cytometry part A: the Journal of the International Society for Analytical Cytology 1-9.
82. Sorokulova IB, Olsen EV, Chen I-H, Fiebor B, Barbaree JM, Vodyanoy VJ, Chin BA, Petrenko VA (2005) Landscape phage probes for Salmonella typhimurium. J Microbiol Methods 63:55-72
83. Sperinde JJ, Choi SJ, Szoka FC (2001) Phage display selection of a peptide DNase II inhibitor that enhances gene delivery. J Gene Med 3:101-8
84. Sternberg N, Hoess RH (1995) Display of peptides and proteins on the surface of bacteriophage lambda. Proc Natl Acad Sci U S A 92:1609-13
85. Sternberg N, Weisberg R (1977) Packaging of coliphage lambda DNA II. The role of the gene D protein. Gene 117:733-759
86. Szybalski W, Bovre K, Fiandt M, Guha A, Hradecna Z, Kumar S, Lozeron HA, Maher VM, Nijkamp HJ, Summers WC, Taylor K (1969) Transcriptional controls in developing bacteriophages. J Cell Physiol 74(Suppl 1):33-70
87. Tanji Y, Shimada T, Yoichi M, Miyanaga K, Hori K, Unno H (2004) Toward rational control of Escherichia coli O157:H7 by a phage cocktail. Appl Microbiol Biotechnol 64:270-4
88. Tao P, Mahalingam M, Marasa BS, Zhang Z, Chopra AK, Rao VB (2013) In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine. Proc Natl Acad Sci U S A 110:4-9
89. Thomas BS, Nishikawa S, Ito K, Chopra P, Sharma N, Evans DH, Tyrrell DLJ, Bathe OF, Rancourt DE (2012) Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage subunit vaccine. Vaccine 30:998-1008
90. Turnbough CL (2003) Discovery of phage display peptide ligands for species-specific detection of Bacillus spores. J Microbiol Methods 53:263-271
91. Vaccaro P, Pavoni E, Monteriù G, Andrea P, Felici F, Minenkova O (2006) Efficient display of scFv antibodies on bacteriophage lambda. J Immunol Methods 310:149-58
92. Vilchez S, Jacoby J (2004) Display of biologically functional insecticidal toxin on the surface of lambda phage. Appl Environ 70:6587-6594
93. Villaverde A, Benito A, Viaplana E, Cubarsi R (1993) Fine regulation of c1857-controlled gene expression in continuous culture if recombinant Escherichia coli by temperature. Appl Environ Microbiol 59:3485-3487
94. Wendt JL, Feiss M (2004) A fragile lattice: replacing bacteriophage lambda's head stability gene D with the shp gene of phage 21 generates the Mg2+-dependent virus, lambda shp. Virology 326:41-6
95. Westwater C, Kasman LM, Schofield DA, Werner PA, Dolan JW, Schmidt MG, Norris JS (2003) Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.
96. Willats WGT (2002) Phage display: practicalities and prospects. Plant Mol Biol 50:837-854
97. Witkiewiczl H, Schweiger M (1982) The head protein D of bacterial virus chromosomal proteins. EMBO J 1:1559-1564
98. Wurtz M, Kistler J, Hohn T (1976) Surface structure of in vitro assembled bacteriophage lambda polyheads. J Mol Biol 101:39-56
99. Yang F, Forrer P, Dauter Z, Conway JF, Cheng N, Cerritelli ME, Steven AC, Plückthun A, Wlodawer A (2000) Novel fold and capsid-binding properties of the λ-phage display platform protein gpD. Nat Struct Biol 7:230-237
100. Zanghi CN, Lankes HA, Bradel-Tretheway B, Wegman J, Dewhurst S (2005) A simple method for displaying recalcitrant proteins on the surface of bacteriophage lambda. Nucleic Acids Res 33:e160
101. Zanghi CN, Sapinoro R, Bradel-Tretheway B, Dewhurst S (2007) A tractable method for simultaneous modifications to the head and tail of bacteriophage lambda and its application to enhancing phage-mediated gene delivery. Nucleic Acids Res 35:e59
102. Zucconi A, Dente L, Santonico E, Castagnoli L, Cesareni G (2001) Selection of ligands by panning of domain libraries displayed on phage lambda reveals new potential partners of synaptojanin 1. J Mol Biol 307:1329-39